Lundbeck
HLUN-B.CO
#2428
Rank
โ‚น512.19 B
Marketcap
โ‚น536.62
Share price
-0.13%
Change (1 day)
31.70%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Revenue for Lundbeck (HLUN-B.CO)

Revenue in 2024 (TTM): โ‚น248.98 Billion

According to Lundbeck 's latest financial reports the company's current revenue (TTM ) is โ‚น252.32 Billion. In 2023 the company made a revenue of โ‚น241.25 Billion an increase over the revenue in the year 2022 that were of โ‚น213.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lundbeck from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น248.98 B3.2%
2023 โ‚น241.25 B12.91%
2022 โ‚น213.67 B12.56%
2021 โ‚น189.83 B-5.38%
2020 โ‚น200.62 B8.2%
2019 โ‚น185.41 B-6.02%
2018 โ‚น197.28 B16.07%
2017 โ‚น169.96 B7.88%
2016 โ‚น157.55 B9.61%
2015 โ‚น143.74 B-4.12%
2014 โ‚น149.91 B-10.5%
2013 โ‚น167.50 B18.22%
2012 โ‚น141.69 B-9.7%
2011 โ‚น156.92 B34.23%
2010 โ‚น116.90 B-3.07%
2009 โ‚น120.60 B